ID   STALP_HUMAN             Reviewed;         436 AA.
AC   Q96FJ0; B3KPA7; Q5T9N4; Q5T9N9; Q7Z420; Q9P2H4;
DT   19-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   23-NOV-2004, sequence version 2.
DT   10-MAY-2017, entry version 128.
DE   RecName: Full=AMSH-like protease;
DE            Short=AMSH-LP;
DE            EC=3.4.19.-;
DE   AltName: Full=STAM-binding protein-like 1;
GN   Name=STAMBPL1; Synonyms=AMSHLP, KIAA1373;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   SUBCELLULAR LOCATION.
RC   TISSUE=Peripheral blood lymphocyte;
RX   PubMed=12810066; DOI=10.1016/S0006-291X(03)01009-X;
RA   Kikuchi K., Ishii N., Asano H., Sugamura K.;
RT   "Identification of AMSH-LP containing a Jab1/MPN domain metalloenzyme
RT   motif.";
RL   Biochem. Biophys. Res. Commun. 306:637-643(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=10718198; DOI=10.1093/dnares/7.1.65;
RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVI.
RT   The complete sequences of 150 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 7:65-73(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-25 AND SER-242, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-242, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.2 ANGSTROMS) OF 263-436 IN COMPLEXES WITH
RP   ZINC IONS AND WITH LYS-63-LINKED DI-UBIQUITIN, FUNCTION, COFACTOR, AND
RP   MUTAGENESIS OF GLU-292; GLU-329; PHE-332; THR-353; PHE-355; SER-357;
RP   SER-358; ASP-360; MET-370; CYS-402 AND PHE-407.
RX   PubMed=18758443; DOI=10.1038/nature07254;
RA   Sato Y., Yoshikawa A., Yamagata A., Mimura H., Yamashita M.,
RA   Ookata K., Nureki O., Iwai K., Komada M., Fukai S.;
RT   "Structural basis for specific cleavage of Lys 63-linked polyubiquitin
RT   chains.";
RL   Nature 455:358-362(2008).
RN   [11]
RP   ERRATUM.
RX   DOI=10.1038/nature07515;
RA   Sato Y., Yoshikawa A., Yamagata A., Mimura H., Yamashita M.,
RA   Ookata K., Nureki O., Iwai K., Komada M., Fukai S.;
RL   Nature 456:274-274(2008).
CC   -!- FUNCTION: Zinc metalloprotease that specifically cleaves 'Lys-63'-
CC       linked polyubiquitin chains. Does not cleave 'Lys-48'-linked
CC       polyubiquitin chains. {ECO:0000269|PubMed:18758443}.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000269|PubMed:18758443};
CC       Note=Binds 2 Zn(2+) ions per subunit.
CC       {ECO:0000269|PubMed:18758443};
CC   -!- INTERACTION:
CC       Q9P209:CEP72; NbExp=7; IntAct=EBI-745021, EBI-739498;
CC       Q3T906:GNPTAB; NbExp=3; IntAct=EBI-745021, EBI-1104907;
CC       Q08379:GOLGA2; NbExp=3; IntAct=EBI-745021, EBI-618309;
CC       Q9UKT9:IKZF3; NbExp=3; IntAct=EBI-745021, EBI-747204;
CC       Q0VD86:INCA1; NbExp=3; IntAct=EBI-745021, EBI-6509505;
CC       Q8IWV1:LAX1; NbExp=3; IntAct=EBI-745021, EBI-10232942;
CC       P43360:MAGEA6; NbExp=5; IntAct=EBI-745021, EBI-1045155;
CC       Q8ND90:PNMA1; NbExp=3; IntAct=EBI-745021, EBI-302345;
CC       P61019:RAB2A; NbExp=8; IntAct=EBI-745021, EBI-752037;
CC       Q9H0A6:RNF32; NbExp=2; IntAct=EBI-745021, EBI-724829;
CC       P15884:TCF4; NbExp=3; IntAct=EBI-745021, EBI-533224;
CC       P14373:TRIM27; NbExp=5; IntAct=EBI-745021, EBI-719493;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q96FJ0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96FJ0-2; Sequence=VSP_014648;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC       {ECO:0000269|PubMed:12810066}.
CC   -!- DOMAIN: The JAMM motif is essential for the protease activity.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the peptidase M67C family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA92611.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=CAI13863.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB010120; BAC77766.1; -; mRNA.
DR   EMBL; AB037794; BAA92611.1; ALT_INIT; mRNA.
DR   EMBL; AK056086; BAG51619.1; -; mRNA.
DR   EMBL; AL157394; CAI13861.1; -; Genomic_DNA.
DR   EMBL; AL157394; CAI13862.1; -; Genomic_DNA.
DR   EMBL; AL157394; CAI13863.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CH471066; EAW50156.1; -; Genomic_DNA.
DR   EMBL; BC010846; AAH10846.2; -; mRNA.
DR   CCDS; CCDS7391.1; -. [Q96FJ0-1]
DR   RefSeq; NP_065850.1; NM_020799.3. [Q96FJ0-1]
DR   RefSeq; XP_006717991.1; XM_006717928.2. [Q96FJ0-1]
DR   RefSeq; XP_006717993.1; XM_006717930.3. [Q96FJ0-1]
DR   RefSeq; XP_011538285.1; XM_011539983.1. [Q96FJ0-1]
DR   RefSeq; XP_011538287.1; XM_011539985.1. [Q96FJ0-1]
DR   RefSeq; XP_016871942.1; XM_017016453.1. [Q96FJ0-1]
DR   RefSeq; XP_016871943.1; XM_017016454.1. [Q96FJ0-1]
DR   RefSeq; XP_016871944.1; XM_017016455.1. [Q96FJ0-1]
DR   RefSeq; XP_016871945.1; XM_017016456.1. [Q96FJ0-1]
DR   UniGene; Hs.16229; -.
DR   UniGene; Hs.701879; -.
DR   PDB; 2ZNR; X-ray; 1.20 A; A=264-436.
DR   PDB; 2ZNV; X-ray; 1.60 A; A/D=264-436.
DR   PDBsum; 2ZNR; -.
DR   PDBsum; 2ZNV; -.
DR   ProteinModelPortal; Q96FJ0; -.
DR   SMR; Q96FJ0; -.
DR   BioGrid; 121614; 48.
DR   IntAct; Q96FJ0; 36.
DR   MINT; MINT-1444179; -.
DR   STRING; 9606.ENSP00000360992; -.
DR   MEROPS; M67.003; -.
DR   iPTMnet; Q96FJ0; -.
DR   PhosphoSitePlus; Q96FJ0; -.
DR   BioMuta; STAMBPL1; -.
DR   DMDM; 71153542; -.
DR   EPD; Q96FJ0; -.
DR   MaxQB; Q96FJ0; -.
DR   PaxDb; Q96FJ0; -.
DR   PeptideAtlas; Q96FJ0; -.
DR   PRIDE; Q96FJ0; -.
DR   Ensembl; ENST00000371924; ENSP00000360992; ENSG00000138134. [Q96FJ0-1]
DR   Ensembl; ENST00000371926; ENSP00000360994; ENSG00000138134. [Q96FJ0-1]
DR   Ensembl; ENST00000371927; ENSP00000360995; ENSG00000138134. [Q96FJ0-2]
DR   GeneID; 57559; -.
DR   KEGG; hsa:57559; -.
DR   UCSC; uc001kfk.5; human. [Q96FJ0-1]
DR   CTD; 57559; -.
DR   DisGeNET; 57559; -.
DR   GeneCards; STAMBPL1; -.
DR   H-InvDB; HIX0009014; -.
DR   HGNC; HGNC:24105; STAMBPL1.
DR   HPA; HPA040202; -.
DR   MIM; 612352; gene.
DR   neXtProt; NX_Q96FJ0; -.
DR   OpenTargets; ENSG00000138134; -.
DR   PharmGKB; PA142670864; -.
DR   eggNOG; KOG2880; Eukaryota.
DR   eggNOG; COG1310; LUCA.
DR   GeneTree; ENSGT00390000015439; -.
DR   HOGENOM; HOG000195792; -.
DR   HOVERGEN; HBG058519; -.
DR   InParanoid; Q96FJ0; -.
DR   KO; K11867; -.
DR   OMA; PDYCDME; -.
DR   OrthoDB; EOG091G06CJ; -.
DR   PhylomeDB; Q96FJ0; -.
DR   TreeFam; TF323215; -.
DR   Reactome; R-HSA-5689901; Metalloprotease DUBs.
DR   ChiTaRS; STAMBPL1; human.
DR   EvolutionaryTrace; Q96FJ0; -.
DR   GeneWiki; STAMBPL1; -.
DR   GenomeRNAi; 57559; -.
DR   PRO; PR:Q96FJ0; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000138134; -.
DR   CleanEx; HS_STAMBPL1; -.
DR   ExpressionAtlas; Q96FJ0; baseline and differential.
DR   Genevisible; Q96FJ0; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0061578; F:Lys63-specific deubiquitinase activity; TAS:Reactome.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008237; F:metallopeptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0016579; P:protein deubiquitination; TAS:Reactome.
DR   InterPro; IPR000555; JAMM/MPN+_dom.
DR   InterPro; IPR015063; USP8_dimer.
DR   Pfam; PF01398; JAB; 1.
DR   Pfam; PF08969; USP8_dimer; 1.
DR   SMART; SM00232; JAB_MPN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Hydrolase; Metal-binding; Metalloprotease; Phosphoprotein;
KW   Polymorphism; Protease; Reference proteome; Ubl conjugation pathway;
KW   Zinc.
FT   CHAIN         1    436       AMSH-like protease.
FT                                /FTId=PRO_0000194874.
FT   DOMAIN      264    373       MPN.
FT   MOTIF       347    360       JAMM motif.
FT   METAL       347    347       Zinc 1; catalytic.
FT   METAL       349    349       Zinc 1; catalytic.
FT   METAL       360    360       Zinc 1; catalytic.
FT   METAL       362    362       Zinc 2.
FT   METAL       402    402       Zinc 2.
FT   METAL       408    408       Zinc 2.
FT   METAL       410    410       Zinc 2.
FT   SITE        292    292       Indirect zinc-binding.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES      25     25       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     242    242       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     420    436       CKHVLVKDIKIIVLDLR -> QKFLSGIISGTALEMEPLKI
FT                                GYGPNGFPLLGISRSSSPSEQL (in isoform 2).
FT                                {ECO:0000303|PubMed:10718198}.
FT                                /FTId=VSP_014648.
FT   VARIANT     196    196       S -> N (in dbSNP:rs12254856).
FT                                /FTId=VAR_051817.
FT   VARIANT     204    204       E -> K (in dbSNP:rs34270879).
FT                                /FTId=VAR_051818.
FT   VARIANT     210    210       A -> T (in dbSNP:rs9988723).
FT                                /FTId=VAR_051819.
FT   MUTAGEN     292    292       E->A: Complete loss of catalytic
FT                                activity. {ECO:0000269|PubMed:18758443}.
FT   MUTAGEN     329    329       E->A: 3-fold decrease in substrate
FT                                affinity. {ECO:0000269|PubMed:18758443}.
FT   MUTAGEN     332    332       F->A: 12-fold decrease in substrate
FT                                affinity, little effect on catalytic
FT                                activity. {ECO:0000269|PubMed:18758443}.
FT   MUTAGEN     353    353       T->A: 19-fold decrease in activity, no
FT                                change in substrate affinity.
FT                                {ECO:0000269|PubMed:18758443}.
FT   MUTAGEN     355    355       F->A: 161-fold decrease in activity, no
FT                                change in substrate affinity.
FT                                {ECO:0000269|PubMed:18758443}.
FT   MUTAGEN     357    357       S->A: 34-fold decrease in activity.
FT                                {ECO:0000269|PubMed:18758443}.
FT   MUTAGEN     358    358       S->A: 10-fold decrease in activity, no
FT                                change in substrate affinity.
FT                                {ECO:0000269|PubMed:18758443}.
FT   MUTAGEN     360    360       D->A: Complete loss of catalytic
FT                                activity. {ECO:0000269|PubMed:18758443}.
FT   MUTAGEN     370    370       M->A: 18-fold decrease in substrate
FT                                affinity, little effect on catalytic
FT                                activity. {ECO:0000269|PubMed:18758443}.
FT   MUTAGEN     402    402       C->S: 402-fold decrease in activity,
FT                                slight increase in substrate affinity.
FT                                {ECO:0000269|PubMed:18758443}.
FT   MUTAGEN     407    407       F->A: 35-fold decrease in activity,
FT                                slight increase in substrate affinity.
FT                                {ECO:0000269|PubMed:18758443}.
FT   STRAND      269    272       {ECO:0000244|PDB:2ZNR}.
FT   HELIX       275    287       {ECO:0000244|PDB:2ZNR}.
FT   TURN        288    290       {ECO:0000244|PDB:2ZNR}.
FT   STRAND      294    302       {ECO:0000244|PDB:2ZNR}.
FT   STRAND      305    313       {ECO:0000244|PDB:2ZNR}.
FT   STRAND      316    319       {ECO:0000244|PDB:2ZNR}.
FT   STRAND      322    325       {ECO:0000244|PDB:2ZNR}.
FT   HELIX       328    338       {ECO:0000244|PDB:2ZNR}.
FT   STRAND      341    348       {ECO:0000244|PDB:2ZNR}.
FT   STRAND      350    352       {ECO:0000244|PDB:2ZNR}.
FT   HELIX       358    370       {ECO:0000244|PDB:2ZNR}.
FT   STRAND      375    380       {ECO:0000244|PDB:2ZNR}.
FT   HELIX       381    383       {ECO:0000244|PDB:2ZNR}.
FT   STRAND      385    391       {ECO:0000244|PDB:2ZNR}.
FT   HELIX       393    401       {ECO:0000244|PDB:2ZNR}.
FT   STRAND      416    419       {ECO:0000244|PDB:2ZNR}.
FT   STRAND      421    426       {ECO:0000244|PDB:2ZNR}.
FT   STRAND      431    434       {ECO:0000244|PDB:2ZNR}.
SQ   SEQUENCE   436 AA;  49783 MW;  722662C76A734102 CRC64;
     MDQPFTVNSL KKLAAMPDHT DVSLSPEERV RALSKLGCNI TISEDITPRR YFRSGVEMER
     MASVYLEEGN LENAFVLYNK FITLFVEKLP NHRDYQQCAV PEKQDIMKKL KEIAFPRTDE
     LKNDLLKKYN VEYQEYLQSK NKYKAEILKK LEHQRLIEAE RKRIAQMRQQ QLESEQFLFF
     EDQLKKQELA RGQMRSQQTS GLSEQIDGSA LSCFSTHQNN SLLNVFADQP NKSDATNYAS
     HSPPVNRALT PAATLSAVQN LVVEGLRCVV LPEDLCHKFL QLAESNTVRG IETCGILCGK
     LTHNEFTITH VIVPKQSAGP DYCDMENVEE LFNVQDQHDL LTLGWIHTHP TQTAFLSSVD
     LHTHCSYQLM LPEAIAIVCS PKHKDTGIFR LTNAGMLEVS ACKKKGFHPH TKEPRLFSIC
     KHVLVKDIKI IVLDLR
//
